New Drug Achieves 100% Success in Treating Bowel Cancer
TL;DR
An immunotherapy drug, Jemperli (dostarlimab) from GSK, has shown unprecedented results in treating locally advanced mismatch repair deficient (dMMR) rectal cancer, achieving a 100% success rate in a clinical trial without the need for surgery or chemotherapy. The trial, presented at the ASCO conference, involved 42 patients who all showed no evidence of disease after treatment. This breakthrough could significantly change the standard of care for this type of bowel cancer.
- Bowel cancer: Drug treatment found to be 100% effective GB News
- Drug that ‘melts away’ tumours could replace surgery for bowel cancer, say doctors The Guardian
- Two wonder drugs that 'melt away' colon cancers in up to 100 PERCENT of patients could help halt epidemic in y Daily Mail
- Drug already available on NHS could help cure deadly form of bowel cancer The Telegraph
- New bowel cancer drug is found to be 100% effective Gloucestershire Live
Want the full story? Read the original reporting
Read on GB News